LYME DISEASE BIOBANK FOUNDATION (EIN 473975911) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

2015

Legal Domicile

Principal Officer

liz horn

Phone

5038634494

Tax Period

2023-01-01 to 2023-12-31

LYME DISEASE BIOBANK FOUNDATION, founded in 2015, is a small nonprofit in the Diseases & Disorders sector that reported $829K in total revenue in fiscal year 2023. Revenue decreased 18% compared to the prior year. Expenses of $729K left a modest 12% surplus.

Mission

TO ADVANCE KNOWLEDGE AND FACILITATE RESEARCH OF THE PATHOGENESIS, DIAGNOSIS AND TREATMENT OF LYME DISEASE AND OTHER TICK-BORNE INFECTIONS.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2023)

Revenue Breakdown

Contributions & Grants $813,619

Program Service Revenue $15,498

Investment Income $0

Other Revenue $0

TOTAL REVENUE $829,117

Expense Breakdown

Grants Paid $0

Salaries & Benefits $164,135

Fundraising Expenses $0

Program Expenses $714,865

Other Expenses $565,087

TOTAL EXPENSES $729,222

Year-over-Year Comparison

	2023	2022	Change
Revenue	$829,117	$1,014,899	-0.2%
Expenses	$729,222	$956,573	-0.2%
Net Income	$99,895	$58,326	+0.7%

Key Indicators

✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✓ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

N/A

Volunteers

N/A

Governance Policies

✗ Conflict of Interest Policy

✗ Whistleblower Policy

✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

$358,728

Total Directors

$451,047

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
LINDA GIAMPA	Director	3.0	Director	$0	$9,897	$259,047
WENDY ADAMS	DIRECTOR, TREASURER	13.4	Officer Director	$0	$0	$192,000
LIZ HORN	PRESIDENT	17.4	Officer	$166,728	$0	$166,728
BONNIE CRATER	DIRECTOR, SECRETARY	0.08	Officer Director	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2024	No data	No data	No data	No data
2023	$829,117	$729,222	$77,403	$99,895
2022	$1,014,899	$956,573	$87,022	$58,326
2021	$737,856	$898,459	$99,221	$-160,603
2020	$778,814	$817,600	$153,062	$-38,786
2019	$875,059	$993,300	$181,055	$-118,241
2018	$596,017	$683,588	$323,761	$-87,571

LYME DISEASE BIOBANK FOUNDATION